2-Cyclopenten-1-one, 2-hydroxy-3,4-dimethyl-
Common Name: |
2-Cyclopenten-1-one, 2-hydroxy-3,4-dimethyl- |
IUPAC Name: |
2-hydroxy-3,4-dimethylcyclopent-2-en-1-one |
Molecular Formula: |
C7H10O2 |
SMILES: |
CC1CC(=O)C(=C1C)O |
Inchi: |
1S/C7H10O2/c1-4-3-6(8)7(9)5(4)2/h4,9H,3H2,1-2H3 |
Inchi Key: |
GXUQPCUHTNAVRJ-UHFFFAOYSA-N |
Cas No: |
21835-00-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
126.15 |
Mass (g/mol) |
126.068 |
Molar Refractivity |
34.95 |
Net Charge |
|
HBD |
1 |
HBA |
2 |
Rt Bonds |
0 |
Rings |
1 |
TPSA |
37.30 |
Hetero Atoms |
2 |
Heavy Atoms |
9 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
245.00 to 247.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.005 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.57 |
LogP |
1.427 |
iLOGP |
1.55 |
XLOGP3 |
0.64 |
WLOGP |
1.43 |
MLOGP |
0.31 |
ESOL Log S |
-1.03 |
ESOL Solubility (mg/ml) |
11.9 |
ESOL Solubility (mol/l) |
0.094 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.00 |
Ali Solubility (mg/ml) |
12.7 |
Ali Solubility (mol/l) |
0.1 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.05 |
Silicos-IT Solubility (mg/ml) |
11.1 |
Silicos-IT Solubility (mol/l) |
0.09 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.62 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.497 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.485 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |